#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Asthma Dermatitis atopic Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pleomorphic liposarcoma Neonatal alloimmune thrombocytopenia Hepatobiliary cancer Acute myeloid leukaemia (in remission) Dedifferentiated liposarcoma Usher's syndrome Multiple system atrophy Acute graft versus host disease in intestine Vitamin B12 deficiency Carcinoid syndrome Antiphospholipid antibodies Atypical haemolytic uraemic syndrome CDKL5 deficiency disorder SAPHO syndrome Cholestatic pruritus More trials…

    Learn about Rare Diseases

    Indolent systemic mastocytosis – Trials in Disease Glomerulonephritis membranous – Treatment Thrombotic thrombocytopenic purpura Mantle cell lymphoma refractory – Treatment Epidermolysis bullosa – Trials in Disease Focal segmental glomerulosclerosis – Diagnostics Familial amyotrophic lateral sclerosis – Trials in Disease Uterine leiomyosarcoma – Trials in Disease Ocular melanoma – Treatment Haemophagocytic lymphohistiocytosis – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Mva-209-Fsp-B4 Resmetirom Olmesartan Medoxomil Fremanezumab Hexaminolevulinate Samuraciclib Ganirelix Pf-07220060 Monohydrate Ixekizumab AUR200 Jk08 Aavanc80-5'Hotof Neridronate Sodium Alclometasone Dipropionate Bi 1839100 MEGESTROL ACETATE Meldonium Cisatracurium Besilate Avibactam Anidulafungin More therapies…

    Learn about Your Condition

    Polycystic ovarian syndrome Anal incontinence Diabetic ketoacidosis Lichen sclerosus Radicular pain Proteus syndrome Oropharyngeal cancer recurrent Necrotising myositis Leiomyosarcoma metastatic Bone hypertrophy Transplant rejection Spinal muscular atrophy Erythema migrans Gender dysphoria Food allergy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Adrenogenital syndrome

  • A Study of Atumelnant for Children with Congenital Adrenal Hyperplasia

    Recruiting

    4 1
    Investigated Drugs:
    • ATUMELNANT
    Belgium France Germany Italy The Netherlands Poland

  • Study of crinecerfont oral solution in children under 2 years old with congenital adrenal hyperplasia to evaluate safety and how the drug works in the body

    Recruiting

    2 1 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • Crinecerfont
    Germany

  • Study on the Safety and Effectiveness of CRN04894 for Patients with Congenital Adrenal Hyperplasia

    Recruiting

    2 1 1
    Investigated Drugs:
    • ATUMELNANT
    Austria France Germany Italy The Netherlands Poland +1

  • Study on the Effectiveness of Dexamethasone in Preventing Prenatal Virilization in Female Patients with Congenital Adrenal Hyperplasia

    Recruiting

    2 1 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • Dexamethasone
    Germany

  • A Study Testing Atumelnant Compared to Placebo in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Steroid Dose While Controlling Hormones

    Recruiting

    3 1
    Investigated Diseases:
    • Adrenogenital syndrome
    Investigated Drugs:
    • ATUMELNANT
    Austria France Germany Italy The Netherlands Poland +1

  • Study of Crinecerfont in Adults with Classic Congenital Adrenal Hyperplasia to Reduce Androgen Levels

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Crinecerfont
    Austria Bulgaria Czechia Germany Italy Portugal +3
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!